New gel to ease rosacea patients' plight

Topical vasoconstrictors are emerging as the first truly evidence-based treatment for rosacea, a leading dermatologist says.

A gel formulation of alpha-adrenergic agonists can be used to obtain long-term symptomatic relief of facial reddening when patients do not respond to basic measures to eliminate trigger factors, according to Professor Roy Chan, director of the National Skin Centre of Singapore.

Speaking at the Asian Congress of Dermatology in Hong Kong last week, Professor Chan said the